Related Experiment Video
Updated: Mar 13, 2026
Advanced Confocal Microscopy Techniques to Study Protein-protein Interactions and Kinetics at DNA Lesions
Published on: November 12, 2017
Utilizing fluorescent life time imaging microscopy technology for identify carriers of BRCA2 mutation
Tamar Zahavi1, Gilad Yahav2, Yael Shimshon3
1Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel; Genomic Bioinformatics Laboratory, Department of Molecular Biology, Ariel University, Ariel, Israel.
A new study shows fluorescent lifetime imaging microscopy can distinguish BRCA2 mutation carriers from others. This simple method may help identify women at higher risk for breast cancer, especially those with unknown mutations.
Area of Science:
- Oncology
- Genetics
- Biophysics
Background:
- Breast cancer is the most common female malignancy globally, with over a million diagnoses annually.
- Germline mutations in BRCA1 and BRCA2 genes significantly elevate breast cancer risk (up to 87%).
- Identifying mutation carriers enables early detection and prevention strategies, but current tests are costly and time-consuming.
Purpose of the Study:
- To develop a simpler, more accessible method for identifying BRCA1 and BRCA2 mutation carriers.
- To evaluate the utility of Fluorescent Lifetime (FLT) imaging microscopy in distinguishing between carriers and non-carriers.
Main Methods:
- Peripheral blood lymphocytes were analyzed using Fluorescent Lifetime (FLT) imaging microscopy.
- FLT values were compared between lymphocytes from BRCA1 mutation carriers, BRCA2 mutation carriers, and non-carrier women.
Main Results:
- Lymphocytes from BRCA2 mutation carriers exhibited significantly lower FLT values compared to BRCA1 mutation carriers and control groups.
- The FLT imaging method demonstrated sensitivity in differentiating cell populations based on mutation status.
Conclusions:
- Fluorescent Lifetime (FLT) imaging microscopy offers a simple, inexpensive, and sensitive approach for detecting BRCA2 mutation carriers.
- This method holds potential for future clinical application, particularly for identifying carriers with unknown functional mutations.
More Related Videos
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022